Furthermore, a study revealed that remdesivir, while used to combat COVID-19, may have adverse effects such as nausea, elevated ALT, and constipation (Panda et al., 2020), indicating that drug toxicity plays a critical role in the occurrence of GI injury among COVID-19 patients. Here, GPT is linked to COVID-19.